Search

everythinglearnresearchcommunity

for

Search:↓

Different skin conditions show distinct types of vessel inflammation, a new quality of life index for vulval disease is reliable, a certain intrauterine system might be linked to chronic vaginal yeast infections, and oral minoxidil reduces hair loss in women.

Aging affects hair density and skin health, and Behcet's disease, a complex condition with no specific test, involves sores and systemic issues, treated with various medications.

The document discusses how to identify and manage common skin conditions in children.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

A woman with Lupus Vasculitis improved after treatment with steroids and other medications.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Most lupus patients in coastal Kerala had skin-specific lesions that could help diagnose the disease, and non-specific skin issues were linked to more severe, systemic lupus.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.